Idalid Franco: Great conference for all new investigators to attend

Idalid Franco shared a post on X:

”Final day of NRG Oncology 2024. Headed to the Gyn Cancer Committee meeting to hear an overview of all the ovarian, uterine corpus, cervix, and vulvar clinical trial updates. Great conference for all new investigators to attend.”

Source: Idalid Franco/X

Idalid Franco is a Radiation Oncologist and inaugural Director of Equity, Access, and Inclusion for the Department of Radiation Oncology at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School. She is a national leader and innovator in the DEI space, creating multiple initiatives that have increased awareness on the important role of diversity, equity, and inclusion within radiation oncology.

The NRG Oncology Summer 2024 meeting took place from July 25-27 at the Sheraton Denver Downtown Hotel in Denver, CO. This in-person event provided a collaborative and constructive learning environment for clinicians, researchers, and industry members to engage with the latest advancements in cancer research. Select sessions were also available via Zoom, ensuring wider accessibility. Attendees had the opportunity to discuss, learn, and develop new ideas, fostering significant progress in the fight against cancer.